Modification of swelling-contraction-aggregation processes in rat muscle mitochondria by the 1,4-dihydropyridines, cerebrocrast and glutapyrone, themselves and in the presence of azidothymidine

Cell Biochemistry and Function

Volumn 15, Issue 3, 1997, Pages 211-220

  Velena, Astrida ^a   Skujiņš, Arnis ^a   Svirskis, Šimons ^a   Bisenieks, Egils ^a   Uldriķis, Janis ^a   Poikans, Janis ^a   Duburs, Gunars ^a   Kluša, Vija ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

1,4 Dihydropyridines; Azidothymidine (AZT); Cerebrocrast; Glutapyrone; High amplitude swelling contraction aggregation; Oxidative phosphorylation; Rat muscle mitochondria; Substrate oxidation

Indexed keywords

1,4 DIHYDROPYRIDINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CEREBROCRAST; DIHYDROPYRIDINE DERIVATIVE; GLUTAPYRONE; SUCCINIC ACID; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; MITOCHONDRIAL MYOPATHY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; MUSCLE MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RAT;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTICONVULSANTS; ANTIMETABOLITES; CELL RESPIRATION; DIHYDROPYRIDINES; DRUG INTERACTIONS; GLUTAMATES; HINDLIMB; MALE; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL SWELLING; MUSCLE CONTRACTION; MUSCLE, SKELETAL; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; RATS; RATS, WISTAR; SUCCINIC ACID; ZIDOVUDINE;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0030761376     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0844(199709)15:3<211::AID-CBF743>3.0.CO;2-L     Document Type: Article

References (44)

1. Dalakas, M. C., Illa, I., Pezeshkpour, G. H., Laukaitis, J. P., Cohen, B. and Griffin, J L. (1990). Mitochondrial myopathy caused by long-term zydovudine therapy. N. Engl. J. Med., 322, 1098-1105.
2. Dalakas, M. (1994). HIV or zidovudine myopathy? Neurology, 44, 360.
3. Mhiri, C., Boudrimont, M., Bonne, G , Geny, C., Degoul, F., Marsac, C., Roullet, E. and Gherardi, R. (1991). Zidovudine myopathy: a distinctive disorder associated with mitochondrial disfunction. Ann. Neurol., 29, 606-614.
4. Chariot, P. and Gherardi, R (1991). Partial cytochrome C oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy. Neuromusc. Disorder, 1, 357-363.
5. Chariot, P., Monnet, I. and Gherardi, R. (1993). Cytochrome C oxidase reaction improves histopathological assessment of zidovudine myopathy. Ann. Neurol., 34, 561-565.
6. Peters, B. S., Winer, J., Landon, D. N., Stotter, A. and Pinching, A. J (1993). Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS. Quart. J. Med., 86, 5-15.
7. Pindado, M. T. C., Bravo, A. L., Martinerodriguez, R., Talevera, A. P., Aguado, F. G., Contreras, M R., Alvarez, M. J. P., Garcia, A. F. and Martin, M. J. A. (1994). Histochemical and ultrastructural-changes induced by zidovudine in mitochondria of rat cardiac muscle. Eur. J. Histochem., 38, 311-318.
8. Seminomora, M. C., Leonmonzon, M. E. and Dalakas, M. C. (1994). Effects of L-carnitine on the zidovudine-induced destruction of human myotubes. 1. L-Carnitine prevents the myotoxicity of AZT in vitro. Lab. Invest., 71, 102-112.
9. Seminomora, M. C , Leonmonzon, M. E. and Dalakas, M. C. (1994). The effect of L-carnitine on the AZT-induced destruction of human myotubes. 2. Treatment with L-carnitine improves the AZT-induced changes and prevents further destruction. Lab. Invest., 71, 773-781.
10. Bakker, H D., Scholte, H. R., Jeneson, J. A. L., Busch, H. F. M., Abeling, N G. G. M. and van Gennip, A. H. (1994). Vitamin-responsive complex-I deficiency in a myopathic patient with increased activity of the terminal respiratory- chain and lactic-acidosis. J. Inherit. Metab. Dis., 17, 196-204.
11. Nussbaum, N. J. and Joseph, P. E. (1996). AZT incorporation into mitochondria: study in human myeloid cell line. DNA Cell Biol., 15, 363-366.
12. Cupler, E. J., Danon, M. J., Jay, C., Hench, K., Ropka, M. and Dalakas, M. C. (1995). Early features of zydovudine-associated myopathy - histopathological findings and clinical correlations. Acta Neuropathol., 90, 1-6
13. Modica-Napolitano, J. S. (1993). AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. Biochm. Biophys. Res. Commun , 194, 170-177.
14. Kumsärs, K. K , Velēna, A. H., Duburs, G. Ya., Uldriķis, Ya, R. and Zidermane, A. A. (1971). The action of various 1,4-dihydropyridine and 1,6-dihydropyrimidine derivatives on the energy metabolism of hepatic and tumour cells. Biokhimia, 36, 1204-1209 (in Russian).
15. Velēna, A. H. (1974). Evaluation of action of antioxidanst - derivatives of 1,4-dihydropyridine on biological membranes and their models. A thesis. Latvian Academy of Science, Riga: Institute of Organic Synthesis (in Russian).
16. 2+ lipid peroxidation in mitochondrial membranes in vitro. Vopr. Med. Khim., 22, 665-673 (in Russian)
17. Velēna, A. H., Auziņš, A. A. and Duburs, G. Ya. (1982). Inhibition of exogenic phospholipase A by means of 1,4-dihydropyridine derivatives. In: Perspectives of Bioorganic Chemistry in New Drug Design. (Čipéns, G., Dubur, G. and Luka, R., eds.) Abstract, All-Union Symposium, Riga, p. 254 (in Russian).
18. Veinberga, Z. A., Velēna, A. H., Andersons, P. P. and Duburs, G. Ya. (1979). Influence of antioxidants on some parameters of metabolism in the organism of chickens. In: Digestion and Absorbtion of Foods by Animals, (Šmits, A., Valdmans, A., Baumane, V. and Ozols, A., ed.) 'Zinātne': Riga. pp. 165-171 (in Russian).
19. 2+ symport with anions in heart and liver mitochondria. In: Problems of Modern Biochemistry and Biotechnology. (Severin, S E., Alagarova, M. B , and Birnova, R. L., eds ) Abstract of papers of 8th joint Symposium of the Biochemical Society. USSR-GDR, Riga, Abstract No 24, p. 68.
20. Velēna, A. H., Duburs, G J , Vïtoliņa, R. O., Ķimenis, A. A., Selga, M. J., Zarinsh, G. V., Naruševičius, E. V., Mac̄ianskiene, R. A., Gendviliene, V. I. and Simkhovich, B. Z. (1985). Effect of ryodipine on electromechanical parameters of heart and vessels, cAMP phosphodiesterase activity and swelling-contraction cycle of mitochondria. Arzneim.-Forsch./Drug Res., 35(1), 907-914.
21. Vïtolinya, R. O., Bērzinya, D. A , Velēna, A. Kh., Vutsina, I. A., Ķimenis, A. A. and Duburs, G. Ya. (1987). The protective effects of the calcium antagonist foridon in acute myocardial ischaemia. Kardiologia (Cardiology), 27, 90-93.
22. 2+ antagonist binding sites with an inner mitochondrial membrane anion channel. Naunyn-Schmiedeberg's Arch. Pharmacol.,341(Suppl.), R43.
23. Baydoun, A. R., Marham, A., Morgan, R. M. and Sweetman, A. J. (1990). BAY K 8644, modifer of calcium transport and energy metabolism in rat heart mitochondria: a new intracellular site of action. Brit. J. Pharmacol., 101, 15-20.
24. Bodor, N. S. (1989). Dihydropyridine-pyridinium redox carrier for brain specific drug delivery. U.S. Patent no. 4, 829,070 (May 9, 1989).
25. Kawczynski, W., Torrence, P. F., Kinjo, J. E. and Czochraiska. B. (1994). Electrochemical study of a pyridine analog of 3′-azido-3′-deoxythymidine (AZT) related to AIDS dementia. Bioelectrochem. Bioenerg., 33, 171-179.
26. Bulow, A and Johansson, B (1994). Membrane stretch evoked by cell swelling increases contractile activity in vascular smooth-muscle through dihydrophyridine-sensitive pathways. Acta Physiol. Scand., 152, 419-427.
27. Makarova, N. V., Biseniex, E. A., Uldriķis, Y. R., Dubur, G. Y., Vēveris, M. M. and Ķimenis, A. A. (1989). Alkoxyand phenoxyalkyl esters of 2,6-dimethyl-4-(2-difluoromethoxyphenyl)-1,4-dihydropyridine-3,5-carboxylic acid. U.S. Pat. no. 4,845,109, 04 07.89.: Application no. 219,843, 08.07.88.
28. Kluša, V (1995). Cerebrocrast. Drugs of the Future, 20, 135-138.
29. Khagi, Kh., Klētnieks, U., Sïle, V., Meirena, D and Sjakste, N. (1992). Antihypoxic effect of IOS-1.1212 (Cerebrocrast). Lai. ZA Vestis. B. (Proc. Latvian Acad. Sci.), No. 9 (542), 84-86
30. Biseniex, E. A., Dubur, G. Y., Uldriķis, Y. R., Vēveris, M. M , Kimenis, A. A. and Ivanov, E. V. (1984). 2-(2,6-Dimethyl-3,5-diethyoxycarbonyl-1,4-dihydropyridine-4-carboxamide)glutaric acid its disodium salt and method of their preparation U.S Patent no. 4,485,239, 27.11.84.; Application no. 536,899, 28.09.83.
31. Klus̄a, V., Ģērmane, S., Mishlyakova, N., Muceniece, R., Dambrova, M. and Svirskis, S (1994). Novel dipeptide-mimicking substances: peculiar modulators of the CNS functioning. Can. J. Physiol. Pharmacol., 72(Suppl. 1), 418 (12th IUPHAR Congress Abstracts).
32. Karpova, M. N , Ģērmane, S. K., Cēbers, G., Pankov, O. Yu., Klus̄a, V. E., Duburs, G. Ya. and Bisenieks, E. (1993). Anticonvulsant properties of Glytapyrone: a novel amino acid-containing 1,4-dihydropyridine derivative. Bull. Exper. Biol. Med., 116, 283-286.
33. Misāne, I., Cēbers, G., Liepa, I., Dambrova, M., Ģērmane, S., Klus̄a, V., Duburs, G. and Bisenieks, E. (1993). Cyclic nootropics, similarity and differences in their memory improving action. Latz, ZA Vētis B. (Proc. Latvian Acad. Sci.), No. 5 (550), 81-85.
34. Vēveris, M. and Cïrule, H. (1991). Antiarrhythmic activity of 1,4-dihydropyridine compounds with and without calcium antagonist properties. In: Pharmacology of Novell Centrally and Peripherally Acting Drugs. (Klǔa, V., Melzobs, M. and Muceniece, R., eds.) Abstracts of the meeting of Estonian. Latvian and Lithuanian Pharmacologits. Riga. Institute of Organic Synthesis, Latvian Academy of Science, p. 76.
35. Hanna, M. G., Nelson, I., Sweeney, M. G., Cooper, J. M., Watkins, P. J., Morgan-Hughes, J. A. and Harding, A. E. (1995). Congenital encephalomyopathy and adultonset myopathy and diabetes mellitus - different phenothypic associations of a new heteroplasmic mtDNA transferRNA glutamic acid mutation. Amer. J. Hum. Gen., 56, 1026-1033.
36. Davis, J. N., Hunnicut, E J , Jr. and Chisholm, J. C. (1995). A mitochondrial bottle-neck hypothesis of Alzheimer's disease. Mol. Med. Today, 1, 240-247.
37. Luft, R. (1994). The development of mitochondrial medicine. Proc. Natl. Acad. Sci., U.S.A., 91, 8731-8738.
38. Hogeboom, G. H , Schneider, W. C. and Pallade, G. E. (1948). Cytochemical studies on mammalian tissues. I Isolation of intact mitochondria from rat liver: some biochemical properties of mitochondria and submicroscopic particulpate material. J Biol. Chem , 172, 619.
39. Lehninger, A. L. (1964). Mitochondrion Molecular Basis of Structure and Function. W. A. Benjamin, Inc : New York. Amsterdam (Russian translation, Moscow, 'Mir', 1996, 315 pp.).
40. Hunter, F. E., Jr., Scott, A., Hoffsten, P. E., Guerra, F., Weinstein, J., Schneider, A , Schutz, E., Fink, J., Ford, L. and Smith, E. (1964). Studies of the mechanism of ascorbate-induced swelling and lysis of isolated liver mitochondria. J. Biol. Chem , 239, 604-613.
41. Azzone, G. F., Massari, S., Pozzan, T. and Pregnolato, L. (1976). Mechanism of active shrinkage in mitochondria. I Coupling between weak electrolyte fluxes. Biochim. Biophys. Acta., 423, 15-26.
42. Poikāns, J., Tirzïtis, G , Bisenieks, E., Uidrikis, J., Gurevich, V S., Mikhailova, I. A. and Duburs, G. (1994). The derivatives of 2,6-dimethyl-1.4-dihydroisonicotinic acid and their antiplatelet properties. Eur. J. Med. Chem., 29, 325-328.
43. Kluša, V., Duburs, G., Velēna, A., Svirskis, S̄. and Skujiņs̄, A. (1995). Neuro- and myoprotective properties of Cerebrocrast and Glutapyrone, the novel endogenous ligand-containing dihydropyridines: focus on the mitochondrial effects. In: HiV-I Infection in the Brain: Towards a Better Understanding of the Pathogenic Events. The Nobel Forum, Karolinska Institute, 2-4 June 1995. Stockholm, Sweden.
44. Kluša, V., Duburs, G. and Velēna, A. (1996). Anti-neurodegenerauve properties of cerebrocrast: focus on cell bioenergetics. Neuropath. Appl. Neurobiol., 22(Suppl. 1), Vth European Congress of Neuropathology. 23-27 April 1996, Hôpital de la Salpêtrièe, Paris, France.